This study is in progress, not accepting new patients
Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia
Summary
- Eligibility
- for people ages 18-50 (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Susan L. Perlman, MD

Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Susan L. Perlman, MD
HS Clinical Professor, Neurology, Medicine. Authored (or co-authored) 182 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Lexeo Therapeutics
- Links
- Sign up for this study
- ID
- NCT05445323
- Phase
- Phase 1/2 research study
- Study Type
- Interventional
- Participants
- About 8 people participating
- Last Updated